Leading specialist pharma consulting group, The Chalfont Project, enhances its offerings to the US market and appoints Cynthia Palka as Head of the US operations

The Chalfont Project’s strong international presence in the bio-pharma consulting arena is now enhanced with a new US lead to facilitate global client relationships. Cynthia Palka has been appointed as VP of US Operations and also Head of the global Leadership Practice.



“This is a significant milestone for the company which has a growing US client base and will benefit from the additional support”, said Dr Leandro Herrero, CEO and one of the founders. “Cynthia has an impressive record as an organisational consultant in the areas of executive coaching and human capital management. I am delighted with her dual appointment as Head of US operations and global Head of the Leadership Practice. We are organisation architects and Cynthia shares our passion for the creation of innovative places to work, strong leadership teams, the application of behavioural sciences to business situations and the development of collaborative spaces for people both inside the firm and between partner and venture companies.”



“The continuous challenges that the bio-pharma industry is facing require specialised, industry-specific consulting services”, said Cynthia Palka. “The Chalfont Project has an exclusive focus on organisational and people management and a track record of project delivery in areas such as organisational re-design, team integration, leadership development and behavioural change management. I am excited by the prospect of joining the global team”





About The Chalfont Project



The Chalfont Project is an organisational architecture, consulting firm offering services to the biopharmaceutical and health care sectors. The company’s four Practices: Organisational Innovation, Leadership, Behavioural Change Management and Human Collaboration, provide consulting services in areas such as behavioural and cultural change, rapid integration of teams in pre/post M&A or internal restructuring, management and leadership development, individual and team coaching, partnerships and alliance management, and organisational redesign and implementation. The company has unique capabilities in the application of behavioural and social sciences to business situations and focuses almost exclusively on the bio-pharmaceutical and health care sectors.